Comparison of measures of medication persistency using a prescription drug database

American Heart Journal

Volumn 153, Issue 1, 2007, Pages 59-65

  Hudson, Marie ^a   Rahme, Elham ^a   Richard, Hugues ^a   Pilote, Louise ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; FEMALE; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DATABASES, FACTUAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; QUEBEC; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33845297688     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.10.018     Document Type: Article

References (17)

1. World Health Organization. Adherence to long-term therapies: evidence for action (2003), World Health Organisation, Geneva
2. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21 (1999) 1074-1090
3. Steiner J.F., and Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50 (1997) 105-116
4. Andrade S.E., Kahler K.H., Frech F., et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15 (2006) 565-574
5. Sikka R., Xia F., and Aubert R.E. Estimating medication persistency using administrative claims data. Am J Manag Care 11 (2005) 453-460
6. Andrade S.E., Walker A.M., Gottlieb L.K., et al. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary-care settings. N Engl J Med 332 (1995) 1125-1131
7. Avorn J., Monette J., Lacour A., et al. Persistence of use of lipid-lowering medications-a cross-national study. JAMA 279 (1998) 1458-1462
8. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 288 (2002) 455-461
9. Jackevicius C.A., Mamdami M., and Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002) 462-467
10. Wei L., Wang J., Thompson P., et al. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 88 (2002) 229-233
11. Perreault S., Blais L., Lamarre D., et al. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 59 (2005) 564-573
12. Blackburn D.E., Dobson R.T., Blackburn J.L., et al. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy 25 (2005) 1035-1043
13. Hudson M., Baron M., Rahme E., et al. Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction. J Rheumatol 32 (2005) 1589-1593
14. Pilote L., Abrahamowicz M., Rodrigues E., et al. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?. Ann Intern Med 141 (2004) 102-112
15. Zhou Z., Rahme E., Abrahamowicz M., et al. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 162 (2005) 1016-1023
16. Tamblyn R., Lavoie G., Petrella L., et al. The use of prescription claims databases in pharmacoepidemiologic research-the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 48 (1995) 999-1009
17. Applegate W.B. Elderly patients' adherence to statin therapy. JAMA 288 (2002) 495-497